Skip to main content
Clinical Trials/NCT03717948
NCT03717948
Completed
Not Applicable

Examining the Impact of Acute Blood Flow Restricted Aerobic Exercise on PGC-1α mRNA Expression in Young Healthy Males: A Randomized Cross-over Trial

Queen's University1 site in 1 country13 target enrollmentStarted: October 1, 2018Last updated:

Overview

Phase
Not Applicable
Status
Completed
Enrollment
13
Locations
1
Primary Endpoint
Peroxisome proliferator-activated receptor gamma coactivator 1-alpha (PGC-1α) messenger ribonucleic acid (mRNA)

Overview

Brief Summary

This crossover study investigates the effects of restricting arterial blood flow during cycling exercise on PGC-1α and its upstream signalling pathways. In a randomized order, participants will exercise once for 30 minutes with restricted blood flow and then will exercise once for 30 minutes with no blood flow restriction.

Study Design

Study Type
Interventional
Allocation
Randomized
Intervention Model
Crossover
Primary Purpose
Basic Science
Masking
Double (Investigator, Outcomes Assessor)

Masking Description

Allocation concealment, assessor blinding

Eligibility Criteria

Ages
18 Years to 30 Years (Adult)
Sex
Male
Accepts Healthy Volunteers
Yes

Inclusion Criteria

  • 3 hours of physical activity per week
  • No previous cycling training
  • No concurrent involvement in another training program
  • Body mass index \< 30 kg/m2

Exclusion Criteria

  • Presence of cardiovascular disease
  • Presence of metabolic disease
  • Taking regular oral medication
  • Current smoker

Outcomes

Primary Outcomes

Peroxisome proliferator-activated receptor gamma coactivator 1-alpha (PGC-1α) messenger ribonucleic acid (mRNA)

Time Frame: 15 minutes before exercise and 3 hours post-exercise for both exercise sessions

Fold-change in PGC-1α mRNA expression

Secondary Outcomes

  • Catecholamine concentrations(15 minutes before exercise and immediately post-exercise for both exercise sessions)
  • Total and phosphorylated acetyl coenzyme A carboxylase (ACC)(15 minutes before exercise and immediately post-exercise for both exercise sessions)
  • Total and phosphorylated protein kinase A (PKA)(15 minutes before exercise and immediately post-exercise for both exercise sessions)
  • Heart rate (HR)(During both exercise sessions)
  • Total and phosphorylated p38 mitogen-activated protein kinase (MAPK)(15 minutes before exercise and immediately post-exercise for both exercise sessions)
  • Blood lactate(During both exercise sessions (lactate); 15 minutes before and immediately after both exercise sessions)
  • Oxygenated and deoxygenated hemoglobin(During both exercise sessions and up to 10 minutes after (for cuff occlusion))
  • Acetylated p53(15 minutes before exercise and immediately post-exercise for both exercise sessions)
  • Revolutions per minute (RPM)(During both exercise sessions)
  • Ratings of perceived exertion (RPE)(During both exercise sessions)

Investigators

Sponsor Class
Other
Responsible Party
Principal Investigator
Principal Investigator

Brendon Gurd

Associate Professor

Queen's University

Study Sites (1)

Loading locations...

Similar Trials